• 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • Segata N Izard J Waldron L Gevers


    [35] Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60. [36] Friedman J, Alm EJ. Inferring correlation networks from genomic survey data. PLoS Comput Biol 2012;8:e1002687. [37] Ling Z, Liu X, Luo Y, Yuan L, Nelson KE, Wang Y, et al. Pyrosequencing analysis of the human microbiota of healthy Chinese undergraduates. BMC Genomics 2013; 14:390.
    [38] Turnbaugh 186689-07-6 PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027–31.
    [39] Seo I, Jha BK, Suh SI, Suh MH, Baek WK. Microbial profile of the stomach: comparison between normal mucosa and cancer tissue in the same patient. J Bacteriol Virol 2014;44:162–9.
    [40] Li XX, Wong GLH, To KF, Wong VWS, Lai LH, Chow DKL, et al. Bacterial microbiota profiling in gastritis without helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One 2009;4:e7985. [41] Gao ZG, Guo BM, Gao RY, Zhu QC, Qin HL. Microbiota disbiosis is associated with co-lorectal cancer. Front Microbiol 2015;6:20. [42] Jobin C. Colorectal cancer CRC-all about microbial products and barrier function? Nat Rev Gastroenterol Hepatol 2012;9:694–6. [43] Huang XM, Liu XS, Lin XK, Yu H, Sun JY, Liu XK, et al. Role of plasmacytoid dendritic 186689-07-6 and inducible costimulator-positive regulatory T cells in the immunosuppres-sion microenvironment of gastric cancer. Cancer Sci 2014;105:150–8. [44] Li TH, Qin Y, Sham PC, Lau KS, Chu KM, Leung WK. Alterations in gastric microbiota after H. Pylori eradication and in different histological stages of gastric carcinogene-sis. Sci Rep UK 2017;7:44935. [45] Pan KF, Zhang L, Gerhard M, Ma JL, Liu WD, Ulm K, et al. A large randomised con-trolled intervention trial to prevent gastric cancer by eradication of Helicobacter py-lori in Linqu County, China: baseline results and factors affecting the eradication. Gut 2016;65:9–18.
    [46] Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187–94.
    [47] Lee YC, Chen TH, Chiu HM, Shun CT, Chiang H, Liu TY, et al. The benefit of mass erad-ication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 2013;62:676–82. [48] Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbi-ota: friends or foes? Nat Rev Immunol 2010;10:735–44. [49] Kienesberger S, Cox LM, Livanos A, Zhang XS, Chung J, Perez-Perez GI, et al. Gastric Helicobacter pylori infection affects local and distant microbial populations and host responses. Cell Rep 2016;14:1395–407.
    [50] Engstrand L, Lindberg M. Helicobacter pylori and the gastric microbiota. Best Pract Res Clin Gastroenterol 2013;27:39–45. [51] Lofgren JL, Whary MT, Ge Z, Muthupalani S, Taylor NS, Mobley M, et al. Lack of com-mensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and de-lays intraepithelial neoplasia. Gastroenterology 2011;140:210–20. [52] Lertpiriyapong K, Whary MT, Muthupalani S, Lofgren JL, Gamazon ER, Feng Y, et al. Gastric colonisation with a restricted commensal microbiota replicates the 
    promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut 2014;63:54–63. [53] Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, Cogliano V. Carcinogenicity of nitrate, nitrite, and cyanobacterial peptide toxins. Lancet Oncol 2006;7:628–9. [54] Peek Jr RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarci-nomas. Nat Rev Cancer 2002;2:28–37. [55] von Rosenvinge EC, Song Y, White JR, Maddox C, Blanchard T, Fricke WF. Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota. ISME J 2013;7:1354–66. [56] Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, Karaoz U, Contreras M, Blaser MJ, et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J 2011;5:574–9.
    [57] Montalban-Arques A, Wurm P, Trajanoski S, Schauer S, Kienesberger S, Halwachs B, et al. Propionibacterium acnes overabundance and natural killer group 2 member D system activation in corpus-dominant lymphocytic gastritis. J Pathol 2016;240: 425–36.
    [58] Andersson AF, Lindberg M, Jakobsson H, Backhed F, Nyren P, Engstrand L. Compara-tive analysis of human gut microbiota by barcoded pyrosequencing. PLoS One 2008; 3:e2836. [59] Dong T, Feng Q, Liu F, Chang LK, Zhou X, Han M, et al. Alteration of stomach micro-biota compositions in the progression of gastritis induces nitric oxide in gastric cell. Exp Ther Med 2017;13:2793–800.